The Biotech Sector is Positioned for a Big 2022 Rebound
The biotechnology sector was one of the worst underperformers in 2021, but this niche of the financial markets could see a big rebound in 2022.
The Biotech Sector is Positioned for a Big 2022 Rebound
Biotechs Reach New All-Time High in 2020
While many investors and traders stare open-mouthed as the Nasdaq and S&P 500 approach their all-time highs in the face of a crippled economy and wave of social injustice protests, there’s one segment of the stock market that has not only reached its previous February 2020 peak, but also surpassed it: the SPDR S&P 500 … Continued